Search Results - "Poliero, Luca"
-
1
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience
Published in Therapeutic advances in medical oncology (2022)“…Background: Recently, new evidence of the next-generation sequencing (NGS) liquid biopsy utility in clinical practice has been developed. This assay is…”
Get full text
Journal Article -
2
Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer
Published in Journal of experimental & clinical cancer research (06-01-2021)“…Despite the advancements in new therapies for colorectal cancer (CRC), chemotherapy still constitutes the mainstay of the medical treatment. For this reason,…”
Get full text
Journal Article -
3
How I treat anal squamous cell carcinoma
Published in ESMO open (01-09-2020)“…Squamous cell carcinoma of the anus (SCCA) is a rising health issue, strongly related to other relevant medical conditions such as (HIV) and human…”
Get full text
Journal Article -
4
Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype
Published in Medical oncology (Northwood, London, England) (01-03-2021)“…A subset of colorectal cancer (CRC) with a mesenchymal phenotype (CMS4) displays an aggressive disease, with an increased risk of recurrence after surgery,…”
Get full text
Journal Article -
5
Immunotherapy in colorectal cancer: is the long-awaited revolution finally happening?
Published in Cancer treatment and research communications (2021)“…Immunotherapy has recently become a major treatment modality for several types of solid tumours, achieving remarkable and long-lasting remissions. In…”
Get full text
Journal Article -
6
Overcoming immune-resistance in laryngeal cancer: a case report of the abscopal effect and nivolumab beyond progression
Published in Immunotherapy (01-10-2022)“…The abscopal effect is defined as the systemic regression of distant neoplastic lesions induced by localized treatment. Although the first case reports date…”
Get full text
Journal Article -
7
Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience
Published in Cancers (08-10-2019)“…Tumor heterogeneity represents a possible cause of error in detecting predictive genetic alterations on tumor tissue and can be overcome by testing alterations…”
Get full text
Journal Article -
8
Abstract 295: Synergism between oxaliplatin or irinotecan with the PARP inhibitor niraparib in a preclinical model of KRAS/BRAF mutated colorectal cancer is associated with MSI status
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…DNA damage response (DDR) is crucial in a variety of tumors and several new drugs that interfere with this mechanism are already available or in advanced…”
Get full text
Journal Article -
9
Abstract 2627: Inhibition of TGFβ in colorectal cancer cells is associated with a compensatory activation of AXL and p38 MAPK signaling pathways
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…According to the consensus molecular subtypes (CMS), almost 23% of human colorectal cancer (CRC) are classified in the CMS4 group, characterized by a…”
Get full text
Journal Article -
10
Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania ‘Luigi Vanvitelli’
Published in ESMO open (30-03-2020)“…BackgroundThe emerging role of next-generation sequencing (NGS) targeted panels is revolutionising our approach to cancer patients, providing information on…”
Get full text
Journal Article